Request Free Sample
×
South America Ascites Market
ID: MRFR/HC/54593-HCR
200 Pages
February 2026
South America Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries), By End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035
Industry Developments
Recent developments in the South America Ascites Market have demonstrated active engagement from major pharmaceutical companies, including Merck, Pfizer, AbbVie, and Gilead Sciences. These firms are increasingly investing in Research and Development to improve ascites management therapies. In September 2023, a strategic partnership was established between Amgen and Novartis focused on novel treatments for abdominal fluid build-up associated with cirrhosis, reflecting a trend towards collaboration for enhanced patient outcomes. Additionally, the market saw growth in company valuations due to rising awareness and investment in liver disease research, currently valued at approximately USD 120 million. This development illustrates the region's urgent need for effective therapeutic solutions. Over the past few years, there have been significant engagements, such as Roche's acquisition of a local biotech firm in June 2022, aimed at expanding its clinical trials in the area. AstraZeneca has also been focusing on increasing its presence in the oncology segment relevant to ascites treatment which further solidifies the growing market landscape. The South American healthcare sector is responding positively to these initiatives, paving the way for advancements in patient care and therapeutic innovation.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 129.0(USD Million) |
| MARKET SIZE 2024 | 136.0(USD Million) |
| MARKET SIZE 2035 | 270.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.433% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Merck, Pfizer, AbbVie, Teva Pharmaceuticals, Gilead Sciences, Biogen, Roche, Eisai, Servier, Novartis, Amgen, Bayer, Sanofi, AstraZeneca, Bristol Myers Squibb |
| SEGMENTS COVERED | Type, Diagnosis, Treatment, End User, Regional |
| KEY MARKET OPPORTUNITIES | Increasing chronic liver disease prevalence, Advancements in treatment options, Growth in healthcare infrastructure, Rising awareness and education, Expanding diagnostic technologies |
| KEY MARKET DYNAMICS | Increasing prevalence of liver diseases, Growing healthcare expenditures, Advancements in diagnostic techniques, Rising demand for effective treatments, Expanding awareness and education initiatives |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
Leave a Comment
FAQs
What is the expected market size of the South America Ascites Market in 2024?
In 2024, the South America Ascites Market is expected to be valued at 136.0 million USD.
What is the projected market size for the South America Ascites Market by 2035?
The market is projected to reach 270.0 million USD by the year 2035.
What is the expected CAGR for the South America Ascites Market from 2025 to 2035?
The expected compound annual growth rate (CAGR) for the market from 2025 to 2035 is 6.433%.
Which region holds the largest market share in the South America Ascites Market?
Brazil is anticipated to hold the largest market share, valued at 30.0 million USD in 2024.
What is the market size for Transudative Ascites in 2024?
The market size for Transudative Ascites is valued at 80.0 million USD in the year 2024.
How much is the Exudate Ascites market expected to be worth in 2035?
The Exudate Ascites market is expected to be worth 110.0 million USD by 2035.
What will be the market value for Argentina in 2024?
Argentina's market for Ascites is valued at 20.0 million USD in 2024.
Who are the key players in the South America Ascites Market?
Key players include Merck, Pfizer, AbbVie, and Gilead Sciences among others.
What will be the market value of the Rest of South America in 2035?
The Rest of South America is projected to reach a market value of 120.0 million USD by 2035.
What are the growth drivers for the South America Ascites Market?
Key growth drivers include increasing incidences of liver disease and advancements in treatment options.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense